pharmaceutical manufacturing

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's Pingshan plant pairs sub-10 ms 5G, zero-touch AGVs and AI inspection to fill 330 million enoxaparin syringes a year on a land-scarce Shenzhen site.

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

BDO’s bioTRAK data shows CDMOs plan about 120 new bioreactors by 2030: 71% of added liters are large-scale stainless steel, but 61% of systems are single-use.

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are expanding their strategic partnership, which began in 2023, with a series of substantial investments aimed at bolstering U.S. pharmaceutical manufacturing. The collaboration, marked by a $750 million investment, focuses on increasing the production of Lilly’s KwikPen®, a

Samsung Biologics reports $262M manufacturing deal running through 2033

Samsung Biologics disclosed a $262 million manufacturing deal with an undisclosed European pharmaceutical company that runs through 2033.

Genentech’s $750M Hillsboro build adds device fill-finish capacity by 2031

Genentech will spend $750 million on a Hillsboro device fill-finish plant for prefilled syringes and autoinjectors, targeting commercial operations in 2031 and creating 250 manufacturing jobs.